Cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and programmed death-1 (PD-1; encoded by the PDCD1 gene) represent crucial immune checkpoints, the blockade of which can potentiate anti-tumour immunity [44, 45]. This evidence concerns the gene PDCD1 and neoplasm.